Dolby Laboratories (NYSE:DLB) SVP Sells $450,666.26 in Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the firm’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the transaction, the senior vice president directly owned 166,803 shares of the company’s stock, valued at $9,804,680.34. The trade was a 4.39% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Dolby Laboratories Trading Up 0.8%

Shares of NYSE DLB traded up $0.46 during trading on Monday, reaching $59.35. The company had a trading volume of 758,552 shares, compared to its average volume of 928,682. Dolby Laboratories has a twelve month low of $48.26 and a twelve month high of $72.96. The stock has a 50-day moving average price of $60.52 and a two-hundred day moving average price of $57.61. The stock has a market capitalization of $5.56 billion, a PE ratio of 25.26 and a beta of 0.78.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The firm had revenue of $305.00 million during the quarter, compared to analysts’ expectations of $311.96 million. During the same quarter last year, the business posted $0.78 EPS. The firm’s quarterly revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, sell-side analysts predict that Dolby Laboratories will post 3.23 EPS for the current year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 19th. Investors of record on Tuesday, August 11th were given a dividend of $0.36 per share. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a yield of 2.4%. Dolby Laboratories’s dividend payout ratio (DPR) is 61.28%.

Dolby Laboratories announced that its board has approved a stock buyback program on Thursday, July 30th that permits the company to repurchase $350.00 million in shares. This repurchase authorization permits the electronics maker to repurchase up to 7% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board believes its shares are undervalued.

Hedge Funds Weigh In On Dolby Laboratories

Hedge funds have recently made changes to their positions in the business. Bank of New York Mellon Corp acquired a new stake in Dolby Laboratories in the 2nd quarter valued at $253,289,000. First Trust Advisors LP boosted its position in shares of Dolby Laboratories by 19.9% in the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after buying an additional 374,405 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Dolby Laboratories by 6.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,321,407 shares of the electronics maker’s stock worth $79,357,000 after buying an additional 83,835 shares during the period. Norges Bank acquired a new stake in shares of Dolby Laboratories in the fourth quarter valued at about $54,966,000. Finally, Fiera Capital Corp grew its stake in shares of Dolby Laboratories by 31.8% in the fourth quarter. Fiera Capital Corp now owns 812,021 shares of the electronics maker’s stock valued at $52,148,000 after buying an additional 195,795 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on DLB. Rosenblatt Securities reissued a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, August 28th. Weiss Ratings raised Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $87.50.

About Dolby Laboratories

Dolby Laboratories, Inc develops audio and imaging technologies for entertainment and communications. The company’s products and intellectual property are used in cinemas, televisions, mobile devices, personal computers, streaming platforms, gaming systems and automobiles to improve sound quality, picture quality and overall viewing experiences.

Dolby’s technology portfolio includes Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and Dolby Digital and Dolby AC-4 audio formats.